Search Within

Nursing

  1. "Clifford Hudis"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (17)
  3. Conference Paper (3)
Groups
  1. Breast Medicine Service (52)
  2. Department of Medicine (52)
  3. Solid Tumor Oncology Division (52)
  4. Survivorship Research (52)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (44)
  6. Epidemiology and Biostatistics (27)

More Groups

People
  1. Clifford Hudis (52)
  2. Larry Norton (38)
  3. Sujata Patil (18)
  4. Andrew Seidman (15)
  5. Teresa Gilewski (15)
  6. Nicola Hamilton (14)

More People

Years
  1. 2017 (2)
  2. 2016 (3)
  3. 2015 (4)
  4. 2014 (2)
  5. 2013 (5)
  6. 2012 (3)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Cancer Research (11)
  3. Breast Cancer Research and Treatment (5)
  4. Clinical Cancer Research (3)
  5. Annals of the New York Academy of Sciences (2)
  6. Cancer Investigation (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. American Association for Cancer Research (14)
  3. Springer (5)
  4. John Wiley & Sons (3)
  5. Biomed Central Ltd (2)
  6. Informa Healthcare (2)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)
    Meeting Abstract

    McArthur, H. L.; Beal, K.; Halpenny, D.; Henrich, M.; Patil, S.; Young, R.; Kaley, T.; Hamilton, N.; Hudis, C.; Wolchok, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling
    Journal Article

    McArthur, H. L.; Diab, A.; Page, D. B.; Yuan, J.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Durack, J. C.; Maybody, M.; Sung, J.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; Haque, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial
    Journal Article

    Basch, E.; Deal, A. M.; Kris, M. G.; Scher, H. I.; Hudis, C. A.; Sabbatini, P.; Rogak, L.; Bennett, A. V.; Dueck, A. C.; Atkinson, T. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
    Meeting Abstract

    Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save